182 related articles for article (PubMed ID: 31115002)
1. Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway.
Yu SY; Peng H; Zhu Q; Wu YX; Wu F; Han CR; Yan B; Li Q; Xiang HG
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3760-3770. PubMed ID: 31115002
[TBL] [Abstract][Full Text] [Related]
2. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway.
Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
4. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
Luo L; Chen C; He H; Cai M; Ling C
Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cichoric Acid on Colorectal Cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
Ma S; Huang Z; Chen Q; Yin X
Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
[TBL] [Abstract][Full Text] [Related]
9. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
11. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
12. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
Chen Z; Liu S; Xia Y; Wu K
Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131
[TBL] [Abstract][Full Text] [Related]
13. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
14. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
Zhang X; Wu J
Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
[TBL] [Abstract][Full Text] [Related]
15. Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis.
Yu Y; Chen F; Jin Y; Yang Y; Wang S; Zhang J; Chen C; Zeng Q; Han W; Wang H; Guo Y; Ni X
Acta Biochim Pol; 2020 Dec; 67(4):595-603. PubMed ID: 33326736
[TBL] [Abstract][Full Text] [Related]
16. Silencing of URG11 expression inhibits the proliferation and epithelial‑mesenchymal transition in benign prostatic hyperplasia cells via the RhoA/ROCK1 pathway.
Zhang G; Zhu F; Han G; Li Z; Yu Q; Li Z; Li J
Mol Med Rep; 2018 Jul; 18(1):391-398. PubMed ID: 29749520
[TBL] [Abstract][Full Text] [Related]
17. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
18. LncRNA AOC4P affects biological behavior of gastric cancer cells through MAPK signaling pathway.
Qu CX; Shi XC; Bi H; Zhai LQ; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8852-8860. PubMed ID: 31696472
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway.
Chen QF; Hu CF; Sun K; Lang YP
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
